[7] etranacogene dezaparvovec costs us$3.5 million per dose This voluntary scheme is based on enhanced interaction and early dialogue with developers of promising medicines, to optimise development plans and speed up evaluation so these medicines can reach patients earlier. The manufacturer claims that the drug will reduce total health care costs because patients will have fewer bleeding incidents and need fewer clotting treatments
Zoe Grace | Plus Size Curvy Model in Olive Dress, Red Top & White Shorts Look - YouTube
Information on valuation, funding, cap tables, investors, and executives for hemgenix
Use the pitchbook platform to explore the full profile.
Hemgenix is manufactured at a lexington, massachusetts site formally owned by uniqure Contract development and manufacturing organization (cdmo) genezen acquired the site earlier this year for $25 million Csl behring, a csl business, will make hemgenix available for eligible people with hemophilia b as soon as possible With the deal, uniqure has effectively outsourced manufacturing of hemgenix, an approved gene therapy for hemophilia b that it licensed to csl and still produced.
